Please assess the completion status of the following clinical trial:

Trial Title: Furosemide vs Placebo for Brain Relaxation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria include:~  * ASA PS I-III~ * Age 18 or older~ * Presenting for elective resection of primary or metastatic supratentorial brain tumor(s)~Exclusion Criteria:~* • ASA PS IV or V~  * Age less than 18~ * Emergency surgery due to severely elevated ICP/impending brainstem herniation~ * Concurrent use of diuretics for any indication~ * Infratentorial/posterior fossa/cerebellar tumor resection~ * Moderate/severe cardiac disease with limitation in contractility as measured by preoperative echocardiogram (EF \< 30%)~ * Severe pulmonary hypertension as measured and/or observed by preoperative studies~ * Preoperative use of steroids (within 6 months, including those on standing doses)~ * Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Furosemide (Type: ACTIVE_COMPARATOR): Furosemide 0.3 mg/kg
- Placebo (Type: PLACEBO_COMPARATOR): Up to 5 mL saline

Based on this trial design, predict the completion outcome and termination type (if applicable).